Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
68Ga-PSMA-I&T
- Development stage
- Preclinical
- Lead developer
- Technical University of Munich
- Modality
- Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Administration
- Intravenous
01
Overview
**68Ga-PSMA-I&T** is a **PSMA-targeted gallium-68 PET radiopharmaceutical** developed as the diagnostic member of the PSMA-I&T theranostic pair for **prostate cancer**. It is a low-molecular-weight urea-based ligand that binds **prostate-specific membrane antigen**, which is highly expressed on many prostate cancer cells, and the attached **gallium-68** radionuclide enables PET visualization of PSMA-expressing lesions after intravenous administration. The agent has been used clinically for prostate cancer staging, restaging, recurrence assessment, and selection of patients for PSMA-directed radioligand therapy, particularly in metastatic castration-resistant disease. The PSMA-I&T scaffold was reported from academic radiopharmaceutical development efforts centered at **Technical University of Munich** with collaboration including **Scintomics** and clinical investigators in Germany.
- Other names
- gallium-68 PSMA I&T68Ga-PSMA Imaging and Therapy68Ga-DOTAGA-PSMA I&TEuK-Subkff-68Ga-DOTAGAEuK-Subkff68Ga-DOTAGAEuK-Subkff 68Ga-DOTAGA68Ga-labeled PSMA I&T
02
Targets
PSMA (Prostate-specific membrane antigen)
Beyond the preview
Go deeper on 68Ga-PSMA-I&T.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on 68Ga-PSMA-I&T.